New questionnaire aims to capture how brain stimulation changes lives
NCT ID NCT05870020
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tests a new questionnaire called DBS-QoLs designed to measure quality of life in people with generalized dystono-dyskinetic syndromes who are treated with continuous electrical neuromodulation (deep brain stimulation). The goal is to see if this tool can reliably assess both physical abilities and emotional well-being, and how patients feel about their treatment. Participants will fill out the questionnaire at the start, after 15 days, and after one year. If successful, this could give doctors a simpler, more complete way to evaluate the real-world impact of brain stimulation therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If validated, this questionnaire could give doctors a better way to understand how deep brain stimulation affects patients' daily lives and emotions.
- What could go wrong
- This is a small, early-stage validation study (33 people) focused on a questionnaire, not a treatment. The scale may not prove reliable or useful in broader practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSTONO-DYSKINETIC SYNDROMES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Montpellier
Montpellier, Hérault, 34295, France